The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
For a definitive list of which limits are mandatory please visit the submission checklist page. We allow the use of up to 6 keywords/key phrases that can be used for indexing purposes. These should ...
Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them. Shared decision making is a joint process in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results